| Tretinoin | Approved Investigational Nutraceutical | CAV2 | 858 |
upregulated | Tretinoin results in increased expression of CAV2 mRNA | 7q31.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CBLN2 | 147381 |
downregulated | Tretinoin results in decreased expression of CBLN2 mRNA | 18q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CBR3 | 874 |
upregulated | Tretinoin results in increased expression of CBR3 mRNA | 21q22.12 | |
| Tretinoin | Approved Investigational Nutraceutical | CBS | 875 |
downregulated | Tretinoin results in decreased expression of CBS mRNA | 21q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CBX2 | 84733 |
downregulated | Tretinoin results in decreased expression of CBX2 mRNA | 17q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CBX3 | 11335 |
downregulated | Tretinoin metabolite results in decreased expression of CBX3 mRNA | 7p15.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CBX3 | 11335 |
downregulated | Tretinoin results in decreased expression of CBX3 mRNA | 7p15.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CBX7 | 23492 |
upregulated | Tretinoin results in increased expression of CBX7 mRNA | 22q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CC2D2A | 57545 |
downregulated | Tretinoin results in decreased expression of CC2D2A mRNA | 4p15.32 | |
| Tretinoin | Approved Investigational Nutraceutical | CCBE1 | 147372 |
downregulated | Tretinoin results in decreased expression of CCBE1 mRNA | 18q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | CCBE1 | 147372 |
upregulated | Tretinoin results in increased expression of CCBE1 mRNA | 18q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | CCDC113 | 29070 |
downregulated | Tretinoin results in decreased expression of CCDC113 mRNA | 16q21 | |
| Tretinoin | Approved Investigational Nutraceutical | CCDC121 | 79635 |
upregulated | Tretinoin results in increased expression of CCDC121 mRNA | 2p23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CCDC126 | 90693 |
upregulated | Tretinoin results in increased expression of CCDC126 mRNA | 7p15.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CCDC136 | 64753 |
downregulated | Tretinoin results in decreased expression of CCDC136 mRNA | 7q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CCDC152 | 100129792 |
downregulated | Tretinoin results in decreased expression of CCDC152 mRNA | 5p12 | |
| Tretinoin | Approved Investigational Nutraceutical | CCDC160 | 347475 |
downregulated | Tretinoin results in decreased expression of CCDC160 mRNA | Xq26.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CCDC177 | 56936 |
downregulated | Tretinoin results in decreased expression of CCDC177 mRNA | 14q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CCDC186 | 55088 |
downregulated | Tretinoin results in decreased expression of CCDC186 mRNA | 10q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CCDC22 | 28952 |
upregulated | Tretinoin results in increased expression of CCDC22 mRNA | Xp11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | CCDC28A | 25901 |
upregulated | Tretinoin results in increased expression of CCDC28A mRNA | 6q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CCDC3 | 83643 |
downregulated | Tretinoin results in decreased expression of CCDC3 mRNA | 10p13 | |
| Tretinoin | Approved Investigational Nutraceutical | CCDC74B | 91409 |
upregulated | Tretinoin results in increased expression of CCDC74B mRNA | 2q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CCDC78 | 124093 |
downregulated | Tretinoin results in decreased expression of CCDC78 mRNA | 16p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CCDC80 | 151887 |
upregulated | Tretinoin results in increased expression of CCDC80 mRNA | 3q13.2 | |